Family C G-Protein-Coupled Receptors in Alzheimer’s Disease and Therapeutic Implications
Alzheimer’s disease (AD), particularly its sporadic or late-onset form (SAD/LOAD), is the most prevalent (96–98% of cases) neurodegenerative dementia in aged people. AD’s neuropathology hallmarks are intrabrain accumulation of amyloid-β peptides (Aβs) and of hyperphosphorylated Tau (p-Tau) proteins,...
Main Authors: | Ilaria Dal Prà, Ubaldo Armato, Anna Chiarini |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-10-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.01282/full |
Similar Items
-
Early Effects of the Soluble Amyloid β<sub>25-35</sub> Peptide in Rat Cortical Neurons: Modulation of Signal Transduction Mediated by Adenosine and Group I Metabotropic Glutamate Receptors
by: Carlos Alberto Castillo, et al.
Published: (2021-06-01) -
G-Protein-Coupled Receptors in CNS: A Potential Therapeutic Target for Intervention in Neurodegenerative Disorders and Associated Cognitive Deficits
by: Shofiul Azam, et al.
Published: (2020-02-01) -
Antagonizing amyloid-β/calcium-sensing receptor signaling in human astrocytes and neurons: a key to halt Alzheimer′s disease progression?
by: Ilaria Dal Prà, et al.
Published: (2015-01-01) -
Danger-Sensing/Patten Recognition Receptors and Neuroinflammation in Alzheimer’s Disease
by: Anna Chiarini, et al.
Published: (2020-11-01) -
Allosteric control of an asymmetric transduction in a G protein-coupled receptor heterodimer
by: Junke Liu, et al.
Published: (2017-08-01)